A Look At Healthcare Realty Trust (HR) Valuation As Recent Returns Show Mixed Momentum

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge.

Healthcare Realty Trust (HR) has drawn investor attention lately as its shares trade around $17.96, with recent returns mixed across the month and past 3 months, and longer term performance showing varied total returns.

See our latest analysis for Healthcare Realty Trust.

Recent trading has been mildly positive, with a 1 month share price return of 4.06% and a year to date share price return of 5.96%. The 1 year total shareholder return of 16.41% contrasts with a softer 3 year total shareholder return of 6.25% and a 5 year total shareholder return of 18.68%, suggesting that shorter term momentum has picked up following a more muted multi year experience.

If you are looking beyond healthcare REITs for what else could be setting up interesting trends, now might be a good time to check out 23 top founder-led companies as a fresh source of ideas.

With shares around $17.96, an indicated 35.18% intrinsic discount and a modest 6.35% gap to the average analyst target, the key question is whether Healthcare Realty Trust is genuinely cheap or if the market is already pricing in future growth.

Most Popular Narrative: 6% Undervalued

Healthcare Realty Trust's most followed narrative pegs fair value at about $19.10 versus the current $17.96 share price, framing a modest valuation gap that depends on future earnings efficiency and cash flow recovery.

Balance sheet strengthening via significant asset dispositions (focused on non-core, low-growth properties), targeted deleveraging, and a right-sized dividend increases financial flexibility for reinvestment. This is positioned to support improved net margins, earnings quality, and greater capital deployment into projects that are expected to generate higher returns.

Read the complete narrative.

Curious what sits behind that $19 handle. The narrative leans heavily on margin repair, steady top line assumptions and a richer earnings multiple. Want to see how those pieces fit together.

Result: Fair Value of $19.10 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, there are real pressure points here, including high leverage and execution risk around asset sales and lease up, which could derail those margin repair hopes.

Find out about the key risks to this Healthcare Realty Trust narrative.

Another Angle on the Valuation

There is a twist when you compare that $19.10 fair value with how the market prices Healthcare Realty Trust on sales. The current P/S is 5.3x, above both the North American Health Care REITs industry at 4.8x and its own fair ratio of 4.8x. This hints at less room for error than the headline discount suggests. So which signal do you trust more: the modelled fair value or the richer sales multiple?

Story continues

See what the numbers say about this price — find out in our valuation breakdown.NYSE:HR P/S Ratio as at Feb 2026

Build Your Own Healthcare Realty Trust Narrative

If this view does not quite fit how you see Healthcare Realty Trust, or you would rather test the numbers yourself, you can build a custom thesis in just a few minutes and Do it your way.

A great starting point for your Healthcare Realty Trust research is our analysis highlighting 1 key reward and 2 important warning signs that could impact your investment decision.

Looking for more investment ideas?

If Healthcare Realty Trust has you thinking more broadly about your portfolio, do not stop here. Use this momentum to refresh your watchlist with new ideas.

Spot potential value opportunities before they are widely discussed by checking out 54 high quality undervalued stocks, which screens for quality companies trading below what their fundamentals might suggest. Strengthen your income stream with 13 dividend fortresses, which focuses on higher yielding companies where payouts play a central role in total returns. Prioritise resilience and capital preservation with 83 resilient stocks with low risk scores, highlighting companies that score well on risk metrics and balance sheet strength.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include HR.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View comments